Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.69 is 40% above its 5-year average of -1.16, near the high end of its 5-year range (-3.19–-0.09).
28.87% above its 12-month average of -0.97.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.12.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 30 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T18:47:54.930Z. Historical observations retain their original dates. Historical series through 2024-08-06.
EARNINGS PER SHARE (EPS)
-0.69
EARNINGS PER SHARE (EPS) AVG TTM
-0.97
EARNINGS PER SHARE (EPS) AVG 3Y
-0.66
EARNINGS PER SHARE (EPS) AVG 5Y
-1.16
EARNINGS PER SHARE (EPS) AVG 10Y
-1.30
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+28.87%
CURRENT VS 3Y AVG
-5.15%
CURRENT VS 5Y AVG
+40.30%
CURRENT VS 10Y AVG
+47.13%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Surgery Partners, Inc.
Market Cap
$1.77B
Earnings Per Share (EPS)
-0.69
TTM Avg
-0.97
3Y Avg
-0.66
5Y Avg
-1.16
Market Cap
$1.77B
Earnings Per Share (EPS)
-1.30
TTM Avg
-1.39
3Y Avg
-1.40
5Y Avg
-0.99
Market Cap
$1.78B
Earnings Per Share (EPS)
-0.80
TTM Avg
-0.89
3Y Avg
-1.03
5Y Avg
-0.96
Market Cap
$1.74B
Earnings Per Share (EPS)
-0.10
TTM Avg
-0.18
3Y Avg
-0.38
5Y Avg
-0.87
Market Cap
$1.79B
Earnings Per Share (EPS)
-2.17
TTM Avg
-2.41
3Y Avg
-1.96
5Y Avg
-1.25
Market Cap
$1.74B
Earnings Per Share (EPS)
-3.36
TTM Avg
-4.53
3Y Avg
-5.16
5Y Avg
-4.47
Market Cap
$1.79B
Earnings Per Share (EPS)
N/A
TTM Avg
-3.33
3Y Avg
-3.33
5Y Avg
-3.33
Market Cap
$1.72B
Earnings Per Share (EPS)
0.19
TTM Avg
-0.34
3Y Avg
-0.57
5Y Avg
-0.59
Market Cap
$1.81B
Earnings Per Share (EPS)
-1.52
TTM Avg
0.75
3Y Avg
-3.08
5Y Avg
-7.20
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Surgery Partners, Inc. (SGRY) | $1.77B | -0.69 | -0.97 | -0.66 | -1.16 |
| Novocure Ltd (NVCR)vs › | $1.77B | -1.30 | -1.39 | -1.40 | -0.99 |
| Absci Corporation (ABSI)vs › | $1.78B | -0.80 | -0.89 | -1.03 | -0.96 |
| Xeris Biopharma Holdings, Inc. (XERS)vs › | $1.74B | -0.10 | -0.18 | -0.38 | -0.87 |
| Xencor, Inc. (XNCR)vs › | $1.79B | -2.17 | -2.41 | -1.96 | -1.25 |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.74B | -3.36 | -4.53 | -5.16 | -4.47 |
| Generate Biomedicines, Inc. (GENB)vs › | $1.79B | N/A | -3.33 | -3.33 | -3.33 |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.72B | 0.19 | -0.34 | -0.57 | -0.59 |
| Novavax, Inc. (NVAX)vs › | $1.81B | -1.52 | 0.75 | -3.08 | -7.20 |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.82B | 2.85 | 2.25 | 1.70 | 1.52 |
Trailing EPS (TTM)
$-0.69
Forward EPS (Est.)
$0.41
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.61 |
| 2024-12-31 | -1.33 |
| 2023-12-31 | -0.09 |
| 2022-12-31 | -0.59 |
| 2021-12-31 | -1.12 |
| 2020-12-31 | -3.19 |
| 2019-12-31 | -2.29 |
| 2018-12-31 | -4.28 |
| 2017-12-31 | -1.09 |
| 2016-12-31 | 0.20 |
| 2015-12-31 | 0.04 |
| 2014-12-31 | -1.37 |
| 2013-12-31 | -0.19 |
| 2012-12-31 | 0.04 |
